Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, 510632, Guangzhou, China.
BSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, 510515, Guangzhou, China.
Signal Transduct Target Ther. 2022 Apr 26;7(1):138. doi: 10.1038/s41392-022-00992-2.
The current pandemic of COVID-19 is fueled by more infectious emergent Omicron variants. Ongoing concerns of emergent variants include possible recombinants, as genome recombination is an important evolutionary mechanism for the emergence and re-emergence of human viral pathogens. In this study, we identified diverse recombination events between two Omicron major subvariants (BA.1 and BA.2) and other variants of concern (VOCs) and variants of interest (VOIs), suggesting that co-infection and subsequent genome recombination play important roles in the ongoing evolution of SARS-CoV-2. Through scanning high-quality completed Omicron spike gene sequences, 18 core mutations of BA.1 (frequency >99%) and 27 core mutations of BA.2 (nine more than BA.1) were identified, of which 15 are specific to Omicron. BA.1 subvariants share nine common amino acid mutations (three more than BA.2) in the spike protein with most VOCs, suggesting a possible recombination origin of Omicron from these VOCs. There are three more Alpha-related mutations in BA.1 than BA.2, and BA.1 is phylogenetically closer to Alpha than other variants. Revertant mutations are found in some dominant mutations (frequency >95%) in the BA.1. Most notably, multiple characteristic amino acid mutations in the Delta spike protein have been also identified in the "Deltacron"-like Omicron Variants isolated since November 11, 2021 in South Africa, which implies the recombination events occurring between the Omicron and Delta variants. Monitoring the evolving SARS-CoV-2 genomes especially for recombination is critically important for recognition of abrupt changes to viral attributes including its epitopes which may call for vaccine modifications.
当前 COVID-19 大流行是由更具传染性的新兴奥密克戎变体推动的。新兴变体持续存在的关注点包括可能的重组,因为基因组重组是人类病毒病原体出现和再现的重要进化机制。在这项研究中,我们鉴定了两种奥密克戎主要亚变体(BA.1 和 BA.2)与其他关切变体(VOCs)和感兴趣变体(VOIs)之间的多种重组事件,表明合并感染和随后的基因组重组在 SARS-CoV-2 的持续进化中发挥了重要作用。通过扫描高质量完成的奥密克戎刺突基因序列,鉴定了 BA.1 的 18 个核心突变(频率>99%)和 BA.2 的 27 个核心突变(比 BA.1 多 9 个),其中 15 个是奥密克戎特有的。BA.1 亚变体与大多数 VOCs 在刺突蛋白中有 9 个共同的氨基酸突变(比 BA.2 多 3 个),这表明奥密克戎可能起源于这些 VOCs。BA.1 比 BA.2 多 3 个与 Alpha 相关的突变,BA.1 在进化上比其他变体更接近 Alpha。在 BA.1 中发现一些主导突变(频率>95%)中存在回复突变。值得注意的是,自 2021 年 11 月 11 日以来在南非分离的“Deltacron”-样奥密克戎变体中也发现了德尔塔刺突蛋白中的多个特征性氨基酸突变,这意味着奥密克戎和德尔塔变体之间发生了重组事件。监测不断演变的 SARS-CoV-2 基因组,特别是重组情况,对于识别病毒属性的突然变化至关重要,包括其表位,这可能需要对疫苗进行修改。